ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2014
Analysis of MRSA-attributed costs of hospitalized patients in Germany.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Estimating the burden of antimicrobial resistance: a systematic literature review.Antimicrobial resistance and infection control · 2018Pooled it
- Plant Metabolites as Potential Agents That Potentiate or Block Resistance Mechanisms Involving β-Lactamases and Efflux Pumps.International journal of molecular sciences · 2025Review
- [Health economic significance of antimicrobial resistance].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025Article
- Prevalence of methicillin sensitive and resistant Staphylococcus aureus carriage among German emergency medical providers.GMS hygiene and infection control · 2024Article
- The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar.Journal of pharmaceutical policy and practice · 2024Article
- Evaluation of the Antibacterial Effect of Aurone-Derived Triazoles onAntibiotics (Basel, Switzerland) · 2023Article
- The Assessment of Antimicrobial and Anti-Biofilm Activity of Essential Oils againstAntibiotics (Basel, Switzerland) · 2023Article
- Interprofessional perceptions of emotional, social, and ethical effects of multidrug-resistant organisms: A qualitative study.PloS one · 2021Article
- Article
- Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data.GMS infectious diseases · 2019Article
- Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.Antimicrobial resistance and infection control · 2019Review
- Risk Factors And Clinical Outcomes Of Hospital-Acquired MRSA Infections In Chongqing, China.Infection and drug resistance · 2019Article
- The effect of isolation precautions on care processes and medical outcomes in patients colonized with MRSA.GMS hygiene and infection control · 2019Article
- Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Article
- Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis.Antimicrobial resistance and infection control · 2018Article
- Letter to the editor in response to estimating the burden of antimicrobial resistance: a systematic literature review.Antimicrobial resistance and infection control · 2018Article
- An overview of the antimicrobial resistance mechanisms of bacteria.AIMS microbiology · 2018Review
- The impact of methicillin-resistantAntimicrobial resistance and infection control · 2017Article
- Economic burden of multidrug-resistant bacteria in nursing homes in Germany: a cost analysis based on empirical data.BMJ open · 2016Article
- Reduction in the incidence of hospital-acquired MRSA following the introduction of a chlorine dioxide 275 ppm based disinfecting agent in a district general hospital.European journal of hospital pharmacy : science and practice · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infections with methicillin-resistant Staphylococcus aureus (MRSA) are assumed to have a high economic impact due to increased hygienic measures and prolonged hospital length of stay. However, surveys on the real expenditure for the prevention and treatment of MRSA are scarce, in particular with regard to the German Diagnosis-Related Groups (G-DRG) payment system. The aim of our study is to empirically assess the additional cost for MRSA management measures and to identify the main cost drivers in the whole process from the hospital's point of view. We conducted a one-year retrospective analysis of MRSA-positive cases in a German university hospital and determined the cost of hygienic measures, laboratory costs, and opportunity costs due to isolation time and extended lengths of stay. A total of 182 cases were included in the analysis. The mean length of hospital stay was 22.75 days and the mean time in isolation was 17.08 days, respectively. Overall, the calculated MRSA-attributable costs were <euro> 8,673.04 per case, with opportunity costs making up, by far, the largest share (77.45 %). Our study provides a detailed up-to-date analysis of MRSA-attributed costs in a hospital. It allows a current comparison to previous studies worldwide. Moreover, it offers the prerequisites to investigate the adequate reimbursement of MRSA burden in the DRG payment system and to assess the efficiency of targeted hygienic measures in the prevention of MRSA.
Indexed as
Identifiers
24838677What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.